Robert Terkeltaub

27.1k total citations · 2 hit papers
269 papers, 17.7k citations indexed

About

Robert Terkeltaub is a scholar working on Nephrology, Rheumatology and Molecular Biology. According to data from OpenAlex, Robert Terkeltaub has authored 269 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Nephrology, 102 papers in Rheumatology and 84 papers in Molecular Biology. Recurrent topics in Robert Terkeltaub's work include Gout, Hyperuricemia, Uric Acid (130 papers), Osteoarthritis Treatment and Mechanisms (41 papers) and Case Reports on Hematomas (38 papers). Robert Terkeltaub is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (130 papers), Osteoarthritis Treatment and Mechanisms (41 papers) and Case Reports on Hematomas (38 papers). Robert Terkeltaub collaborates with scholars based in United States, New Zealand and Australia. Robert Terkeltaub's co-authors include Kristen Johnson, Ru Liu‐Bryan, Martin Lotz, Linda K. Curtiss, James W. Goding, William A. Boisvert, José Luís Millán, Lovisa Hessle, Sonoko Narisawa and David M. Rose and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert Terkeltaub

264 papers receiving 17.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization

2002 685 citations Kristen Johnson, Sonoko Narisawa et al. profile →
Emerging regulators of the inflammatory process in osteoarthritis

2014 512 citations Ru Liu‐Bryan, Robert Terkeltaub profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Terkeltaub United States	77	6.7k	6.3k	5.9k	3.3k	2.7k	269	17.7k
Kerstin Amann Germany	74	1.5k 0.2×	7.5k 1.2×	6.7k 1.1×	2.9k 0.9×	4.3k 1.6×	584	24.4k
Takashi Wada Japan	55	1.4k 0.2×	2.9k 0.5×	3.2k 0.5×	2.0k 0.6×	2.8k 1.0×	454	13.5k
Hui Y. Lan Hong Kong	102	1.9k 0.3×	12.3k 1.9×	16.2k 2.8×	4.8k 1.5×	7.1k 2.6×	467	37.4k
David J. Nikolic‐Paterson Australia	70	1.1k 0.2×	6.0k 0.9×	5.9k 1.0×	2.5k 0.8×	4.7k 1.7×	244	17.6k
Paola Romagnani Italy	68	1.1k 0.2×	3.9k 0.6×	5.5k 0.9×	2.7k 0.8×	6.6k 2.4×	236	18.9k
Wayne A. Border United States	58	1.1k 0.2×	5.4k 0.8×	6.7k 1.1×	2.2k 0.7×	1.4k 0.5×	118	17.0k
Keith A. Hruska United States	68	1.9k 0.3×	5.3k 0.8×	7.1k 1.2×	1.4k 0.4×	643 0.2×	269	15.2k
Detlef Schlöndorff Germany	70	1.3k 0.2×	3.7k 0.6×	4.6k 0.8×	1.5k 0.5×	5.3k 2.0×	237	14.9k
Lorenz C. Hofbauer Germany	71	2.2k 0.3×	1.4k 0.2×	13.4k 2.3×	3.0k 0.9×	2.1k 0.8×	429	24.9k
Helmut G. Rennke United States	63	746 0.1×	7.8k 1.2×	4.2k 0.7×	2.0k 0.6×	1.6k 0.6×	196	16.8k

Countries citing papers authored by Robert Terkeltaub

Since Specialization

Citations

This map shows the geographic impact of Robert Terkeltaub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Terkeltaub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Terkeltaub more than expected).

Fields of papers citing papers by Robert Terkeltaub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Terkeltaub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Terkeltaub. The network helps show where Robert Terkeltaub may publish in the future.

Co-authorship network of co-authors of Robert Terkeltaub

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Terkeltaub. A scholar is included among the top collaborators of Robert Terkeltaub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Terkeltaub. Robert Terkeltaub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukui, Sho, et al.. (2025). Association of Chronic Kidney Disease With Increased Glucose Uptake–Associated Metabolic Activity of Visceral Adipose and Subcutaneous Adipose Tissue in Patients With Gout. Arthritis Care & Research. 77(8). 1022–1031.

Cui, Lingling, Robert Terkeltaub, Xinde Li, et al.. (2025). Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score–Matched Cohort Study. Arthritis Care & Research. 77(9). 1149–1156. 2 indexed citations

Sirotti, Silvia, Antonella Adinolfi, Edoardo Cipolletta, et al.. (2025). Pseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?–The time has come to reconsider the nomenclature of calcium pyrophosphate deposition. Annals of the Rheumatic Diseases. 84(8). 1287–1292. 2 indexed citations

Adinolfi, Antonella, Silvia Sirotti, Edoardo Cipolletta, et al.. (2025). Systematic literature review on Calcium Pyrophosphate Deposition (CPPD) nomenclature: condition elements and clinical states— A Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus project. RMD Open. 11(1). e004847–e004847. 5 indexed citations

McCormick, Natalie, Amit D. Joshi, Chio Yokose, et al.. (2024). Prediagnostic Amino Acid Metabolites and Risk of Gout, Accounting for Serum Urate: Prospective Cohort Study and Mendelian Randomization. Arthritis Care & Research. 76(12). 1666–1674.

Sun, Mingshu, Robert Terkeltaub, Tony R. Merriman, et al.. (2024). Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout. Arthritis & Rheumatology. 76(7). 1130–1140. 5 indexed citations

Heerspink, Hiddo J.L., Austin G. Stack, Robert Terkeltaub, et al.. (2024). Combination Treatment with Verinurad and Allopurinol in CKD. Journal of the American Society of Nephrology. 35(5). 594–606. 15 indexed citations

Wei, Jie, Yan Cui, Jialing Wu, et al.. (2023). POS0090 DYSBIOSIS OF GUT MICROBIOME, BILE ACID COMPOSITIONS, AND PREVALENCE OF HYPERURICEMIA: DATA FROM THE XIANGYA HYPERURICEMIA STUDY. Annals of the Rheumatic Diseases. 82. 258–258. 1 indexed citations

Joshi, Amit D., Natalie McCormick, Chio Yokose, et al.. (2023). Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population‐Based, Prospective Study and Mendelian Randomization Analysis. Arthritis & Rheumatology. 75(9). 1648–1657. 10 indexed citations

10.

Cobo, Isidoro, Roxana Coras, Alyssa Torres, et al.. (2022). Monosodium urate crystals regulate a unique JNK-dependent macrophage metabolic and inflammatory response. Cell Reports. 38(10). 110489–110489. 38 indexed citations

11.

Robinson, Philip C., Robert Terkeltaub, Michael H. Pillinger, et al.. (2021). Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease. The American Journal of Medicine. 135(1). 32–38. 68 indexed citations

12.

Li, Hui, Xiang Ding, Robert Terkeltaub, et al.. (2020). Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior. Arthritis Research & Therapy. 22(1). 34–34. 57 indexed citations

13.

Yokose, Chio, Natalie McCormick, Clara Chen, et al.. (2019). Risk of gout flares after vaccination: a prospective case cross-over study. Annals of the Rheumatic Diseases. 78(11). 1601–1604. 17 indexed citations

14.

Jin, Yunyun, Cong Qian, Jelena Gvozdenovic‐Jeremic, et al.. (2018). Enpp1 inhibits ectopic joint calcification and maintains articular chondrocytes by repressing hedgehog signaling. Development. 145(18). 23 indexed citations

15.

Johnson, Kristen, David M. Rose, & Robert Terkeltaub. (2008). Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation. Journal of Cell Science. 121(13). 2256–2264. 39 indexed citations

16.

Millán, José Luís, Sonoko Narisawa, Isabelle Lemire, et al.. (2007). Enzyme Replacement Therapy for Murine Hypophosphatasia. Journal of Bone and Mineral Research. 23(6). 777–787. 204 indexed citations

17.

Johnson, Kristen, R.G.G. Russell, B. P. Wordsworth, et al.. (2005). Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate.. Queensland's institutional digital repository (The University of Queensland). 3 indexed citations

18.

Bieber, Jeffry D & Robert Terkeltaub. (2004). Gout: On the brink of novel therapeutic options for an ancient disease. Arthritis & Rheumatism. 50(8). 2400–2414. 147 indexed citations

19.

Johnson, Kristen, K. P. H. Pritzker, James W. Goding, & Robert Terkeltaub. (2001). The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles.. PubMed. 28(12). 2681–91. 70 indexed citations

20.

Rosenbach, Michael, D Provvedini, Neil F. Rebbe, et al.. (1994). Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta.. Journal of Clinical Investigation. 94(2). 560–567. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact